PEDIATRIX MEDICAL GROUP INC (MD:NYSE)
$26.23 -0.38 (-1.428%)
Analysed PEDIATRIX MEDICAL GROUP INC (MD:NYSE) News Sources
3 Profitable Stocks That Concern Us
21-08-2026
yahoo.com
Midland and Wallbridge to Test Gold Exploration Targets by Drilling at Casault
27-08-2026
yahoo.com
Pediatrix Medical Group (MD) Q2 Earnings: What To Expect
03-08-2026
yahoo.com
Pediatrix Medical Group Inc (MD) (Q2 2026) Earnings Call Highlights: Strong EBITDA and Payer ...
04-08-2026
yahoo.com
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
06-08-2026
yahoo.com
Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)?
09-08-2026
yahoo.com
Pediatrix Medical Group (MD) Earnings Growth Puts Its Valuation Back In Focus
09-08-2026
yahoo.com
Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
5 Must-Read Analyst Questions From Pediatrix Medical Group’s Q2 Earnings Call
13-08-2026
yahoo.com
Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks
26-08-2026
yahoo.com
What is the current price of PEDIATRIX MEDICAL GROUP INC (MD:NYSE)?
The current price of PEDIATRIX MEDICAL GROUP INC (MD:NYSE) is $26.23.
PEDIATRIX MEDICAL GROUP INC (MD:NYSE) absolute price change since previous trading day?
The absolute price change of PEDIATRIX MEDICAL GROUP INC (MD:NYSE) since the previous trading day is $-0.38.
PEDIATRIX MEDICAL GROUP INC (MD:NYSE) percentage price change since previous trading day?
The percentage price change of PEDIATRIX MEDICAL GROUP INC (MD:NYSE) since the previous trading day is -1.428%.
What is the most recent average sentiment score for PEDIATRIX MEDICAL GROUP INC (MD:NYSE)?
The most recent average sentiment score for PEDIATRIX MEDICAL GROUP INC (MD:NYSE) is 65 out of 100.
What is the most recent average sentiment for PEDIATRIX MEDICAL GROUP INC (MD:NYSE)?
The most recent sentiment for PEDIATRIX MEDICAL GROUP INC (MD:NYSE) is .
SEC-8K** Filing Available For PEDIATRIX MEDICAL GROUP INC (MD:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.